Mobile Site ›

84160:
Erythrocytosis Evaluation

CPT Code Information Current Value

Erythrocytosis Evaluation

82820-Hemoglobin O2 affinity (p50)

83020-Hemoglobin electrophoresis

83021-Hemoglobin A2 and F

82664-IEF confirms

 

Hemoglobin, Unstable, Blood

83068 (if appropriate)

 

Hemoglobin Variant by Mass Spectroscopy (MS), Blood

83789 (if appropriate)

 

Hemoglobin S, Screen, Blood

85660 (if appropriate)

 

Hemoglobin F, Red Cell Distribution, Blood

88184 (if appropriate)

 

Hemoglobin Electrophoresis, Molecular

81257 x 2-HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg. Alpha thalassemia, Hb Bart hydrops fetalis syndrome, HBH disease) gene analysis for common deletions or variant (eg, Southeast Asian, Thai, Filipino, Mediterranean, alpha3.7, alpha4.2, alpha20.5, and Constant Spring) (if appropriate)

81401-HBB (hemoglobin, beta) (eg, sickle cell anemia, hemoglobin C, hemoglobin E), common variants (eg, HbS, HbC, HbE) (if appropriate)

81403-HBB (hemoglobin, beta, beta-globin) (eg, beta thalassemia), duplication/deletion analysis (if appropriate)

81404-HBB (hemoglobin, beta, Beta-Globin) (eg, thalassemia), full gene sequence (if appropriate)

 

Hereditary Erythrocytosis Mutations

81479-Unlisted molecular pathology procedure

 

Von Hippel-Lindau (VHL) Gene, Full Gene Analysis

81404-VHL (von Hippel-Lindau tumor suppressor) (eg, von Hippel-Lindau familial cancer syndrome), full gene sequence


CPT Code Information Value Prior to 1/15/2013 4:03pm

Erythrocytosis Evaluation

82820-Hemoglobin O2 affinity (p50)

83020-Hemoglobin electrophoresis

83021-Hemoglobin A2 and F

82664-IEF confirms

 

Hemoglobin, Unstable, Blood

83068 (if appropriate)

 

Hemoglobin Variant by Mass Spectroscopy (MS), Blood

83789 (if appropriate)

 

Hemoglobin S, Screen, Blood

85660 (if appropriate)

 

Hemoglobin F, Red Cell Distribution, Blood

88184 (if appropriate)

 

Hemoglobin Electrophoresis, Molecular

83891-Isolation or extraction of highly purified nucleic acid (if appropriate)

83898 x 4-Amplification, target, each nucleic acid sequence (if appropriate)

83900-Amplification, target, multiplex, first 2 nucleic acid sequences (if appropriate)

83904 x 12-Mutation identification by sequencing, single segment, each segment (if appropriate)

83909 x 13-Separation and identification by high-resolution technique (if appropriate)

83914 x 8-Mutation identification by enzymatic ligation or primer extension, single segment, each segment (if appropriate)

 

Hereditary Erythrocytosis Mut, B (if appropriate)

Molecular Interpretation

83890-Automated extraction

83912-Interpretation and Report

 

EPOR Gene, Mutation Analysis, B

83900-Amplification, target, multiplex, first 2 nucleic acid sequences

83904 x 4-Mutation identification by DNA sequencing, single segment, each segment

83909 x 4-Separation and identification by high resolution technique

 

HIF2A Gene, Mutation Analysis, B

83900-Amplification, target, multiplex, first 2 nucleic acid sequences

83904 x 4-Mutation identification by DNA sequencing, single segment, each segment

83909 x 4-Separation and identification by high resolution technique

 

PHD2 Gene, Mutation Analysis, B

83900-Amplification, target, multiplex, first 2 nucleic acid sequences

83901 x 3-Amplification, target, multiplex, each additional nucleic acid sequence beyond 2

83904 x 12-Mutation identification by DNA sequencing, single segment, each segment

83909 x 12-Separation and identification by high resolution technique

 

VHL Full Gene Analysis (if appropriate)

81404-VHL (von Hippel-Lindau tumor suppressor) (eg, von Hippel-Lindau familial cancer syndrome), full gene sequence

81403-VHL (von Hippel-Lindau tumor suppressor) (eg, von Hippel-Lindau familial cancer syndrome), deletion/duplication analysis (if appropriate)

 

For nonparticipating payers:

Von Hippel-Lindau (VHL) Gene, Full Gene Analysis

83892 x 2-Enzymatic digestion

83894-Separation by gel electrophoresis

83900-Amplification, target, multiplex, first 2 nucleic acid sequences

83901 x 4-Amplification, target, multiplex, each additional nucleic acid sequence beyond 2

83912-Interpretation and report

 

VHL Gene Sequencing

83909 x 6

 

VHL Deletion Detection

83900-Amplification, target, multiplex, first 2 nucleic acid sequences (if appropriate)

83901 x 14-Amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (if appropriate)

83909-Separation and identification by high-resolution technique (if appropriate)

83914-Mutation identification by enzymatic ligation or primer extension, single segment, each segment (if appropriate)